Mycophenolate mofetil therapy for pediatric bullous pemphigoid
- Author(s): Seminario-Vidal, Lucia;
- Sami, Naveed;
- Miller, Jonathan;
- Theos, Amy
- et al.
Published Web Locationhttps://doi.org/10.5070/D3218028429
Bullous pemphigoid (BP) is a common autoimmune blistering disease in the adult population, but extremely rare in the pediatric population. Childhood BP usually has a favorable prognosis and responds well to topical and oral steroids. However, for patients that do not respond to corticosteroids, therapeutic alternatives are scarce. We report a case of a toddler with recalcitrant BP who was successfully treated with mycophenolate mofetil (MMF).